CM
IGMS

Caption Management’s IGM Biosciences IGMS Stock Holding History

Caption Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-40,000
Closed -$550K – 1253
2023
Q1 		$550K Buy
+40,000
New +$827K 0.01% 771
2021
Q4 		– Sell
-25,000
Closed -$1.64M – 1742
2021
Q3 		$1.64M Hold
25,000
– – 0.02% 845
2021
Q2 		$2.08M Buy
25,000
+10,000
+67% +$741K 0.03% 662
2021
Q1 		$1.15M Buy
+15,000
New +$1.37M 0.02% 652
2020
Q4 		– Sell
-30,000
Closed -$2.21M – 1102
2020
Q3 		$2.21M Buy
+30,000
New +$1.78M 0.05% 401

Other funds holding IGMS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caption Management's IGMS Position: Q4 2021 in Review

Caption Management sold out of IGM Biosciences (IGMS) in Q4 2021, closing a stake of 4,668 shares — an estimated $307K sold.

Caption Management first reported a position in IGMS in Q3 2021 and held it in 1 quarter. The position peaked at $307K in Q3 2021. 87 funds tracked by Wall St. Rank hold IGMS as of Q4 2021.

  • Caption Management reported no remaining IGM Biosciences position as of Q4 2021 after selling out during the quarter.
  • Caption Management sold 4,668 IGM Biosciences shares in Q4 2021, an estimated $307K.
  • Caption Management first reported a position in IGM Biosciences in Q3 2021 and held it in 1 quarter.
  • Caption Management's IGM Biosciences position peaked at $307K in Q3 2021.
  • 87 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.